Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK)
about
Factors Associated with Maternal Serum Levels of Perfluoroalkyl Substances and Organochlorines: A Descriptive Study of Parous Women in Norway and SwedenMaternal Concentrations of Perfluoroalkyl Substances and Fetal Markers of Metabolic Function and Birth Weight.Sociodemographic and Perinatal Predictors of Early Pregnancy Per- and Polyfluoroalkyl Substance (PFAS) Concentrations.Exposure to PFOA and PFOS and fetal growth: a critical merging of toxicological and epidemiological data.Maternal and Neonatal Levels of Perfluoroalkyl Substances in Relation to Gestational Weight GainDemographic, Reproductive, and Dietary Determinants of Perfluorooctane Sulfonic (PFOS) and Perfluorooctanoic Acid (PFOA) Concentrations in Human ColostrumMaternal serum levels of perfluoroalkyl substances and organochlorines and indices of fetal growth: a Scandinavian case-cohort studyPrenatal Exposure to Perfluoroalkyl Substances and Adiposity in Early and Mid-Childhood.Fathers Matter: Why It's Time to Consider the Impact of Paternal Environmental Exposures on Children's Health.Trade-offs of Personal Versus More Proxy Exposure Measures in Environmental Epidemiology.Early life exposure to per- and polyfluoroalkyl substances and mid-childhood lipid and alanine aminotransferase levels.Gestational diabetes and offspring birth size at elevated environmental pollutant exposures.Exposure to Perfluoroalkyl Substances and Metabolic Outcomes in Pregnant Women: Evidence from the Spanish INMA Birth Cohorts.Early Pregnancy Perfluoroalkyl Substance Plasma Concentrations and Birth Outcomes in Project Viva: Confounded by Pregnancy Hemodynamics?Challenges Associated with Applying Physiologically Based Pharmacokinetic Modeling for Public Health Decision-Making.Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial.When do Exposure Biomarkers Reflect More than Just Exposure?Prenatal Exposure to Perfluoroalkyl Substances and Cardiometabolic Risk in Children from the Spanish INMA Birth Cohort Study.Effects of prenatal perfluoroalkyl acid exposure on cord blood IGF2/H19 methylation and ponderal index: The Hokkaido Study.Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA).Prenatal Exposure to Perfluoroalkyl Substances: Infant Birth Weight and Early Life Growth
P2860
Q28553267-1EC32856-1862-49D9-9C7D-DD914473751EQ33564787-15823E64-53B4-4A60-8737-FCEC83165445Q36264053-58CD4AA4-0332-4028-A8CE-1DDAC927CA92Q36406073-40AB130C-DD89-4D3E-9624-E641A0CDFC25Q36513368-99C73639-909B-4E09-BA0A-DF4D2F3D86E5Q37600475-C8C9B6E5-27B9-4E92-A188-3F1781A5BD57Q37647684-0F6C17C3-DB09-4ADD-B02C-49F6D5DF6F73Q37674876-AE6C7E98-9BDC-4E7E-BD63-1DAAE617510FQ38604726-A68E1282-445B-467B-BB73-9C699C0752ABQ40196887-7EFE80D5-3829-4BB4-86DD-ED14ADDFA6E5Q45972435-5D305FE6-0406-4499-A110-C63C4E074DB5Q47197494-E2875690-1B0D-4D03-9768-060DC6F0F3D0Q47405391-41A439C2-1281-4F6E-AE37-E514DB0C1D00Q47789399-19E8C15F-1F54-4863-8D6C-4944844EF7BFQ49551649-5B25200B-3985-4031-9F67-D72CE6DEB5AEQ49644181-6E837854-3F19-43D1-85F8-1A08375C16A7Q49916153-15B7F7E7-612B-4C63-8983-96A8577AFA02Q49960524-5D9F6538-3ED5-49B6-93B4-C556EFB4C5E0Q51554605-FECDA681-0AFC-4378-AB44-C284D42E7E16Q54993802-39079917-1B90-4DF0-9B3F-A912DFD53EF9Q57144626-90A2ED78-419D-4A92-998A-C40BA78FC3F5
P2860
Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK)
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Associations of Perfluoroalkyl ...... d Pharmacokinetic Model (PBPK)
@ast
Associations of Perfluoroalkyl ...... d Pharmacokinetic Model (PBPK)
@en
type
label
Associations of Perfluoroalkyl ...... d Pharmacokinetic Model (PBPK)
@ast
Associations of Perfluoroalkyl ...... d Pharmacokinetic Model (PBPK)
@en
prefLabel
Associations of Perfluoroalkyl ...... d Pharmacokinetic Model (PBPK)
@ast
Associations of Perfluoroalkyl ...... d Pharmacokinetic Model (PBPK)
@en
P2093
P2860
P50
P356
P1476
Associations of Perfluoroalkyl ...... d Pharmacokinetic Model (PBPK)
@en
P2093
Anne E Loccisano
Chihiro Miyashita
Harvey J Clewell
Marc-André Verner
Mei-Huei Chen
Michele Marcus
Reiko Kishi
Robin McDougall
P2860
P304
P356
10.1289/EHP.1408837
P50
P577
2015-05-22T00:00:00Z